GLP-1 agonists and their next-gen successors may still be center stage in the red-hot obesity space, but newly launched ...

Amid an organizational reset, Bayer’s SVP and Global Head of Biotech Jens Vogel, Ph.D., has hit the exits after four years ...

Johnson & Johnson Executive Vice President and Chief External Innovation and Medical Officer William Hait, M.D., Ph.D., will ...

Vyaire Medical has put up the for-sale sign, as it files for Chapter 11 bankruptcy following dropping demand in the wake of ...

GE HealthCare is switching up the leadership of its divisions, as well as the alignment of some of its segments, to better ...

Lokavant has released a new artificial intelligence solution it claims can help contract research organizations and sponsors ...

Charles River Laboratories has launched a new program to come up with an animal-free alternative to inhalation toxicology ...

It remains to be seen whether Sage Therapeutics’ dalzanemdor can improve function in patients with Huntington's disease.

Eli Lilly’s Alzheimer’s treatment sailed through an FDA advisory committee meeting Monday, with panelists praising the ...

After posting preliminary results from the first-in-human trial of its closed-loop neuromodulation implant for urinary ...

In a document (PDF) released publicly June 5, the NIH’s National Institute of Allergy and Infectious Diseases (NIAID) ...

The combo vaccine advanced into phase 3 in fall 2023 after phase 1/2 data similarly showed that mRNA-1083 matched or beat two ...